Latest National Institute of Health Stories
SAN DIEGO, July 31, 2012 /PRNewswire/ -- OrPro Therapeutics, Inc. today announced that the company has been awarded a National Heart, Lung and Blood Institute Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). The grant enables OrPro to advance development of its lead product, ORP-100, for the treatment of cystic fibrosis (CF), an inherited genetic disease that affects approximately 80,000 people worldwide. "This award focuses on an...
ROCKVILLE, Md., July 30, 2012 /PRNewswire/ -- Radiation Control Technologies, Inc. (RCTI), a private development stage biopharmaceutical company developing RCT1938, a novel radiosensitizer that sensitizes tumor cells to killing by radiation while protecting healthy cells from radiation damage by inhibiting the synthesis of the novel target protein CD47, announced today that it has been granted an exclusive license to two patents from the National Institutes of Health (NIH). The...
Viral evolution and host protein levels predict rapid disease progression Scientists at the National Institutes of Health have identified several factors in people infected with the hepatitis C virus that may predict whether the unusually rapid progression of disease from initial infection to severe liver conditions, such as cirrhosis, will occur. Knowing whether a patient's condition is likely to deteriorate quickly could help physicians decide on the best course of treatment. The...
WASHINGTON, July 26, 2012 /PRNewswire-USNewswire/ -- Veterinarian and Colorado State University (CSU) Professor Edward Hoover will receive the Association of American Veterinary Medical Colleges' (AAVMC) 2012 Merial-AAVMC Excellence in Research Award on Saturday, August 4, at the Merial-NIH National Veterinary Scholars Symposium in Colorado. (Photo: http://photos.prnewswire.com/prnh/20120726/DC46565) Dr. Hoover, whose work led to the development of a vaccine for feline leukemia, is...
WASHINGTON, July 25, 2012 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatment of blood disorders, today announced its commitment of $9 million over a three-year period to provide funding, in the form of bridge grants, for its hematologists whose vital research will not be accomplished due to the severe funding reductions for biomedical research. ASH's new grant program was designed...
A bill to authorize the NIH to support the creation of up to 20 pediatric research consortia focused on diseases such as spinal muscular atrophy (SMA) was introduced in the U.S. House of Representatives. Alexandria, VA (PRWEB) July 20, 2012 A bill to authorize the National Institutes of Health (NIH) to support the creation of up to 20 pediatric research consortia focused on diseases such as spinal muscular atrophy (SMA) was introduced yesterday in the U.S. House of Representatives. The...
PITTSBURGH, July 19, 2012 /PRNewswire/ -- Liberty Tire Recycling, the premier provider of tire recycling services in North America, has announced the company will donate its Pinnacle Rubber Mulch and SMARTE playground surface system to KaBOOM!, a national nonprofit organization dedicated to saving play for America's children. The donation, which includes 8,200 square feet of Pinnacle Rubber Mulch for landscaping and 4,400 square feet of SMARTE playground safety surfacing, will be...
The Cancer Genome Atlas generates genomic data for colon and rectal cancers that point to potential targets for treatment The pattern of genomic alterations in colon and rectal tissues is the same regardless of anatomic location or origin within the colon or the rectum, leading researchers to conclude that these two cancer types can be grouped as one, according to The Cancer Genome Atlas (TCGA) project's large-scale study of colon and rectal cancer tissue specimens. In multiple types of...
NIH-supported research provides more complete picture of the disease Researchers have linked newly discovered gene mutations to some cases of the progressive fatal neurological disease amyotrophic lateral sclerosis – ALS, also known as Lou Gehrig's disease. Shedding light on how ALS destroys the cells and leads to paralysis, the researchers found that mutations in this gene affect the structure and growth of nerve cells. ALS attacks motor neurons, the nerve cells responsible for...
A new study details how a suite of web-based tools provides the research community with greatly improved capacity to compare data derived from large collections of genomic information against thousands of drugs. By comparing drugs and genetic targets, researchers can more easily identify pharmaceuticals that could be effective against different forms of cancer. The newly updated software, called CellMiner, was built for use with the NCI-60, one of the most widely utilized collections of...
